HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eleonora Pagnotta Selected Research

Inflammation (Inflammations)

7/2022The Efficacy of Camelina sativa Defatted Seed Meal against Colitis-Induced Persistent Visceral Hypersensitivity: The Relevance of PPAR α Receptor Activation in Pain Relief.
2/2022Beneficial Effects of Eruca sativa Defatted Seed Meal on Visceral Pain and Intestinal Damage Resulting from Colitis in Rats.
6/2021The H2S-Donor Erucin Exhibits Protective Effects against Vascular Inflammation in Human Endothelial and Smooth Muscle Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eleonora Pagnotta Research Topics

Disease

8Neoplasms (Cancer)
03/2019 - 04/2006
3Pain (Aches)
07/2022 - 01/2019
3Inflammation (Inflammations)
07/2022 - 06/2021
3Colonic Neoplasms (Colon Cancer)
06/2006 - 08/2005
2Colitis
07/2022 - 02/2022
2Hypersensitivity (Allergy)
07/2022 - 02/2022
1Reperfusion Injury
12/2023
1Ischemia
12/2023
1Peritonitis
12/2022
1Hyperalgesia
07/2022
1Visceral Pain
02/2022
1Arthritis (Polyarthritis)
02/2022
1Gliosis
02/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2022
1Infections
11/2021
1Body Weight (Weight, Body)
04/2021
1Obesity
04/2021
1Mycoses (Diseases, Fungus)
07/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2019
1Adenocarcinoma
03/2019
1Neuralgia (Stump Neuralgia)
01/2019
1Autolysis
12/2018
1Wounds and Injuries (Trauma)
05/2017
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2009
1Osteosarcoma (Osteogenic Sarcoma)
07/2008
1Genomic Instability
07/2008
1Carcinoma (Carcinomatosis)
08/2005
1Neuroblastoma
07/2003

Drug/Important Bio-Agent (IBA)

6GlucosinolatesIBA
02/2022 - 02/2013
4EnzymesIBA
12/2018 - 06/2006
3erucinIBA
12/2023 - 03/2019
3IsothiocyanatesIBA
04/2021 - 02/2013
39-hydroxystearic acidIBA
06/2006 - 08/2005
22,4-dinitrofluorobenzene sulfonic acidIBA
07/2022 - 02/2022
2AntioxidantsIBA
06/2021 - 04/2012
2glucoerucinIBA
04/2021 - 01/2019
2isothiocyanic acidIBA
03/2019 - 04/2012
2Proteins (Proteins, Gene)FDA Link
06/2009 - 07/2008
2Histone Deacetylase 1IBA
04/2006 - 08/2005
1mitochondrial K(ATP) channelIBA
12/2023
1CalciumIBA
12/2023
1LipopolysaccharidesIBA
12/2022
12,4-dinitrobenzenesulfonic acidIBA
07/2022
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
07/2022
1Therapeutic UsesIBA
07/2022
12,4-dinitrobenzeneIBA
02/2022
1Sulfonic AcidsIBA
02/2022
1Potassium Channels (Potassium Channel)IBA
02/2022
1Anti-Bacterial Agents (Antibiotics)IBA
11/2021
1fumagillinIBA
11/2021
1Glucose (Dextrose)FDA LinkGeneric
04/2021
1Hypoglycemic Agents (Hypoglycemics)IBA
04/2021
1allyl isothiocyanateIBA
07/2019
12,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA
07/2019
1Phosphotransferases (Kinase)IBA
03/2019
1Antineoplastic Agents (Antineoplastics)IBA
03/2019
1Streptozocin (Streptozotocin)FDA Link
01/2019
1nasIBA
12/2018
1Glutathione Transferase (Glutathione S-Transferase)IBA
04/2013
1thioglucosidaseIBA
02/2013
1Histone Deacetylases (Histone Deacetylase)IBA
04/2012
1sulforaphaneIBA
04/2012
1LigandsIBA
06/2009
1DNA (Deoxyribonucleic Acid)IBA
07/2008
1methylformamideIBA
06/2006
1Epidermal Growth Factor (EGF)IBA
04/2006
1Growth InhibitorsIBA
08/2005
1AntibodiesIBA
07/2003

Therapy/Procedure

2Therapeutics
02/2022 - 06/2006
1Aftercare (After-Treatment)
05/2017
1Drug Therapy (Chemotherapy)
09/2012